Welcome to the Safety Beyond Needlestick Prevention Learning Center
Since the implementation of the Needlestick Safety and Prevention Act in November, 2000, we have come a long way in protecting healthcare workers from sharps injuries. However, mucocutaneous related blood exposure continues to occur and be accepted as "part of the job."
The OSHA Bloodborne Pathogen (BBP) standard is inclusive of blood exposure from all sources, including sharps and mucocutaneous exposures. Recent studies show that blood leakage occurs at a rate of 40-50% during IV conventional catheter insertion.1,3 Another study by Jagger et al. found the at-risk mucocutaneous exposure (MCE) during IV catheter insertions is 128 per 100,000 insertions compared to needlestick injury (NSI) rates of 6.6 per 100,000 conventional devices and 0.7 per 100,000 safety devices.2
Advances in safety engineered peripheral IV catheters now incorporate technology to help protect healthcare workers from both sharps and mucocutaneous blood exposure. The combination of advanced products and work practice control (use of personal protective equipment) can help minimize clinician risk.